
Esloric100 mg
Square Pharmaceuticals PLC.
Established / FDA-Approved Uses Chronic gout and gouty arthritis: Long-term management of hyperuricemia in patients with moderate-to-severe recurrent gout, tophaceous gout and more.
| Indication | Typical Adult Dosing |
|---|---|
| Chronic gout / hyperuricemia of gout | Initiate at 100 mg once daily; increase in increments of 100 mg at weekly intervals as needed to reach target serum uric acid, typically to a maintenance dose of 200-300 mg/day for mild disease or 400-600 mg/day for moderate-to-severe tophaceous gout. Maximum recommended dose is 800 mg/day. Doses above 300 mg/day are usually given in divided doses. |
| Secondary hyperuricemia with chemotherapy (tumor lysis prevention) | 600-800 mg/day in divided doses, usually started 1-2 days before initiating chemotherapy, together with adequate hydration. |
| Recurrent calcium oxalate stones with hyperuricosuria | 200-300 mg/day, often as a single daily dose, alongside adequate fluid intake and dietary measures. |
Allopurinol is contraindicated in patients with known hypersensitivity to Allopurinol or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.